ECR GLOBAL
Live / Registered — Registered (as of 03 Sept 2024)
What this means for you
Registered since 03 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97632503
- Registration number
- 7496635
- Mark type
- Design + words
- Filed
- 14 Oct 2022
- Published for opposition
- 17 Oct 2023
- Registered
- 03 Sept 2024
- Attorney of record
- Nazly Aileen Bayramoglu
Goods and services
- Class 035 — Advertising and business services: Advertising relating to pharmaceutical products and in-vivo imaging products; Advertising services; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Rental of advertising space
Owner
- Elixir Clinical Research Co.,Ltd., Shanghai, CN
- Elixir Clinical Research Co.,Ltd., Shanghai, CN
- Elixir Clinical Research Co.,Ltd., Shanghai, CN
Prosecution history
- 03 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 29 Jul 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Jul 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Jun 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 20 May 2024 — USE AMENDMENT FILED
- 26 Jun 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 May 2024 — TEAS STATEMENT OF USE RECEIVED
- 12 Dec 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Oct 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Oct 2023 — PUBLISHED FOR OPPOSITION
- 27 Sept 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Sept 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Sept 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Sept 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE